Jarmo Kulmala

Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

Kaisa Erjala, Maria Sundvall, Teemu T. Junttila et al. · Clinical Cancer Research · 2006 · 265 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiotherapy treatment planning and long-term follow-up with [11C]methionine PET in patients with low-grade astrocytoma

Joanne Nuutinen, Pirkko Sonninen, Pertti Lehikoinen et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 151 citations

Medicine, Nuclear Medicine, Oncology +13

Stage‐Specific Apoptosis in the Rat Seminiferous Epithelium: Quantification of Irradiation Effects

Kenth Henriksén, Jarmo Kulmala, Jorma Toppari et al. · Journal of Andrology · 1996 · 65 citations · Full text

Medicine, Cell Biology, Pathology +17

CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance

Sami Ventelä, Eleonora Sittig, Leni Mannermaa et al. · Oncotarget · 2014 · 63 citations · Full text

Medicine, Oncology, Otolaryngology +8

Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro

Na Zhang, Kaisa Erjala, Jarmo Kulmala et al. · Radiotherapy and Oncology · 2009 · 53 citations

Medicine, Oncology, Radiation Oncology +11